PTPRC and neoplasm: Ten signaling pathways only existed in the lymphatic metastases, including CD22, CD45, IL16, SPP1, LIGHT, ANGPTL, GRN, ncWNT, PERIOSTIN, and NEGR, in addition to the classical ncWNT pathways that can promote tumor progression.